Lucira Health, Inc.
LHDXDelisted Apr 12, 2023- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652724
Lucira Health, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 13, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $1.04M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Lucira Health, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 6 | 1 | −5 |
| Shares | 6.36M | 22.8K | −6.33M (−99.6%) |
| Value | $1.46M | $545 | −$1.46M (−100.0%) |
New holders (0)
Institutions that held Lucira Health, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
None.
Sold out (5)
Institutions that held Lucira Health, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Eclipse Ventures, LLC | 6,223,795 | $1.43M |
| Simplex Trading, LLC | 74,764 | $17.0K |
| Tudor Investment Corp Et Al | 31,002 | $7.00K |
| Barclays PLC | 2,906 | $668 |
| Clear Street LLC | 1,000 | $230 |